Literature DB >> 15645194

[Blood coagulation disorders in oncological patients].

M von Depka Prondzinski1.   

Abstract

Patients with malignancies often experience acute disorders of coagulation. They may manifest as thromboembolism, disseminated intravascular coagulation or a tendency to bleed. Either disorder carries a high rate of complications and a difficult task in diagnosing and treating them. Some complications typical for patients with malignancies are discussed. Among these are tumor associated thrombophilia, acquired von Willebrand's disease, and thrombocytopenia.

Entities:  

Mesh:

Year:  2005        PMID: 15645194     DOI: 10.1007/s00108-004-1329-x

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  26 in total

1.  Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation.

Authors:  F B Taylor; C H Toh; W K Hoots; H Wada; M Levi
Journal:  Thromb Haemost       Date:  2001-11       Impact factor: 5.249

2.  The quantitative relation between platelet count and hemorrhage in patients with acute leukemia.

Authors:  L A GAYDOS; E J FREIREICH; N MANTEL
Journal:  N Engl J Med       Date:  1962-05-03       Impact factor: 91.245

Review 3.  Treatment of von Willebrand's Disease.

Authors:  Pier Mannuccio Mannucci
Journal:  N Engl J Med       Date:  2004-08-12       Impact factor: 91.245

Review 4.  The role of the plasminogen activation system in cancer.

Authors:  V A Carroll; B R Binder
Journal:  Semin Thromb Hemost       Date:  1999       Impact factor: 4.180

5.  Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data.

Authors:  N Levitan; A Dowlati; S C Remick; H I Tahsildar; L D Sivinski; R Beyth; A A Rimm
Journal:  Medicine (Baltimore)       Date:  1999-09       Impact factor: 1.889

Review 6.  Cancer, thrombosis, and anticoagulants.

Authors:  D L Ornstein; L R Zacharski
Journal:  Curr Opin Pulm Med       Date:  2000-07       Impact factor: 3.155

7.  Cancer procoagulant in acute non lymphoid leukemia: relationship of enzyme detection to disease activity.

Authors:  M B Donati; A Falanga; R Consonni; M G Alessio; R Bassan; M Buelli; L Borin; L Catani; E Pogliani; L Gugliotta
Journal:  Thromb Haemost       Date:  1990-08-13       Impact factor: 5.249

Review 8.  Pathogenesis of increased risk of thrombosis in cancer.

Authors:  Hau C Kwaan; Simrit Parmar; Jun Wang
Journal:  Semin Thromb Hemost       Date:  2003-06       Impact factor: 4.180

Review 9.  From Trousseau to targeted therapy: new insights and innovations in thrombosis and cancer.

Authors:  M N Levine; A Y Lee; A K Kakkar
Journal:  J Thromb Haemost       Date:  2003-07       Impact factor: 5.824

10.  Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.

Authors:  Paolo Prandoni; Anthonie W A Lensing; Andrea Piccioli; Enrico Bernardi; Paolo Simioni; Bruno Girolami; Antonio Marchiori; Paola Sabbion; Martin H Prins; Franco Noventa; Antonio Girolami
Journal:  Blood       Date:  2002-07-12       Impact factor: 22.113

View more
  1 in total

1.  [Uncommon tumor-associated deep vein thrombosis].

Authors:  Rosemary Poulose; Anselm A Derda; Mohamed Omar; Christian von Falck; Florian Länger; Jochen Tillmanns; Adrian Groh; Johann Bauersachs; L Christian Napp
Journal:  Internist (Berl)       Date:  2022-02-23       Impact factor: 0.834

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.